gener
use
avian
antibodi
increas
interest
wide
varieti
applic
within
life
scienc
due
phylogenet
distanc
mechan
immun
diversif
way
deposit
igi
immunoglobulin
egg
yolk
chicken
provid
number
advantag
compar
mammal
host
immun
advantag
includ
onestep
purif
antibodi
egg
yolk
larg
amount
facilit
virtual
continu
suppli
epitop
spectrum
avian
antibodi
potenti
grant
access
novel
specif
broad
absenc
crossreact
mammalian
epitop
avoid
assay
interfer
improv
perform
immunolog
techniqu
polyclon
natur
igi
antibodi
limit
use
sinc
avian
hybridoma
techniqu
well
establish
recombin
igi
howev
gener
mammalian
monoclon
antibodi
make
possibl
exploit
advantag
properti
igi
scaffold
moreov
clone
select
immun
repertoir
avian
organ
highli
effici
yield
antigenspecif
antibodi
fragment
recombin
approach
well
suit
circumv
limit
polyclon
antibodi
review
present
comprehens
inform
gener
purif
modif
applic
polyclon
monoclon
igi
antibodi
antibodi
like
remain
affin
molecul
choic
wide
varieti
analyt
biochem
medic
approach
primarili
familiar
properti
use
wellestablish
mani
applic
moreov
specif
biolog
effect
readili
manipul
use
standard
molecular
biolog
techniqu
case
mammalian
antibodi
perfectli
adequ
unfortun
involv
immun
respons
immunemedi
patholog
along
high
degre
conserv
among
mammal
howev
make
suscept
unwant
interact
conserv
protein
turn
hamper
use
certain
approach
immun
chicken
provid
attract
altern
use
mammal
host
antibodi
product
igi
major
low
molecular
weight
immunoglobulin
ovipar
anim
type
antibodi
distinct
properti
exploit
variou
way
research
diagnost
therapi
one
import
advantag
aris
phylogenet
distanc
genet
background
distinguish
bird
mammal
improv
likelihood
immun
respons
elicit
antigen
epitop
may
nonimmunogen
mammal
deposit
igi
egg
yolk
immun
bird
provid
eleg
sourc
polyclon
immunoglobulin
sinc
polyclon
igi
recov
egg
lay
hen
prolong
period
approach
provid
longterm
suppli
substanti
amount
antibodi
addit
antibodi
exhibit
biochem
structur
featur
render
superior
virtual
type
immunoassay
especi
design
detect
molecul
specimen
like
mammalian
blood
serum
due
technic
difficulti
avian
hybridoma
techniqu
problem
exist
immort
b
cell
line
alvinduc
bursaderiv
lymphoma
line
undergo
ig
gene
convers
vitro
cultur
product
chicken
antibodi
languish
somewhat
becam
possibl
gener
monoclon
igi
vitro
select
combinatori
antibodi
librari
phage
display
chicken
singl
function
v
j
segment
present
light
heavi
chain
gene
loci
result
diversif
avian
immun
repertoir
introduc
rearrang
v
j
segment
gene
convers
use
pseudo
v
gene
donor
seen
greatli
simplifi
construct
combinatori
recombin
antibodi
librari
select
power
phage
display
provid
way
access
uniqu
binder
review
focus
immunolog
background
novel
approach
made
possibl
result
avian
antibodi
technolog
suggest
chicken
wide
use
gener
nativ
recombin
igi
igi
predomin
low
molecular
weight
serum
immunoglobulin
isotyp
amphibian
reptil
bird
design
deriv
occurr
egg
yolk
demonstr
transfer
immun
hen
develop
embryo
among
three
avian
isotyp
igi
igm
iga
igi
abund
serum
concentr
rang
mgml
lay
hen
compar
lower
concentr
igm
mgml
iga
mgml
anseriform
bird
like
duck
exist
addit
igi
altern
splice
version
igi
igi
dfc
variant
lack
fc
region
therefor
fcmediat
secondari
effector
function
also
found
rel
substanti
amount
mgml
organ
chicken
respons
antibodi
product
differ
significantli
mammal
central
primari
lymphoid
organ
repres
thymu
bursa
fabriciu
bf
peripher
secondari
lymphoid
organ
includ
spleen
harderian
gland
bone
marrow
conjunctivalassoci
lymphoid
tissu
calt
bronchialassoci
lymphoid
tissu
balt
gutassoci
lymphoid
tissu
galt
chicken
lymph
node
instead
lymphoid
nodul
associ
lymphat
bf
locat
cloaca
caudal
bodi
caviti
play
cardin
role
avian
b
cell
develop
antibodi
diversif
follow
colon
small
number
b
cell
precursor
cell
express
surfac
immunoglobulin
undergo
rapid
prolifer
two
month
age
approxim
follicl
bf
week
hatch
bursal
cell
migrat
day
blood
spleen
thymu
caecal
tonsil
subsequ
produc
immunoglobulin
spleen
largest
secondari
lymphoid
organ
import
antigen
process
product
antibodi
hatch
although
igi
essenti
immunoglobulin
characterist
function
similar
igg
possess
slightli
differ
structur
provid
distinct
properti
biochem
behaviour
igi
slightli
higher
molecular
mass
approxim
kda
mammalian
counterpart
due
presenc
four
constantand
one
variabl
ig
heavi
chain
domain
nucleotid
sequenc
chicken
upsilon
heavi
chain
reveal
ancient
amphibian
igi
avian
molecul
contain
domain
conserv
mammalian
ige
condens
form
flexibl
hing
region
mammalian
igg
ortholog
domain
must
therefor
exist
igylik
ancestor
prior
duplic
subsequ
diverg
mammalian
lineag
mammal
igg
form
immun
complex
facilit
opsonis
activ
complement
system
provid
protect
foetu
upon
transport
across
placenta
ige
sensit
effector
cell
mediat
anaphylact
reaction
igi
appear
combin
mammalian
iggand
igelik
function
sinc
provid
defenc
infect
may
also
mediat
anaphylaxi
contrast
mammal
basophil
much
numer
bird
mast
cell
antibodydepend
hypersensit
fatal
system
anaphylaxi
mainli
mediat
cell
constitut
indirect
evid
presenc
igi
receptor
effector
cell
igi
bind
monocyt
igglik
kinet
despit
put
ige
like
structur
predict
chicken
heavi
chain
primari
sequenc
recent
chicken
leucocyt
receptor
complex
lrc
analys
four
major
type
chicken
iglik
receptor
chir
identifi
chira
activ
receptor
display
two
extracellular
igdomain
chirb
inhibitori
receptor
also
display
two
igdomain
two
type
chirab
one
two
igdomain
report
bifunct
potenti
sinc
display
featur
inhibitori
activ
receptor
far
recent
identifi
homologu
receptor
lrc
known
specif
function
classic
fc
receptor
express
chicken
b
cell
macrophag
monocyt
nk
cell
contrast
igg
ige
receptor
bind
similar
way
fcari
fcrn
stoichiometri
affin
compar
valu
report
iga
bind
receptor
contrast
mammalian
igg
ige
bind
site
map
upsilon
heavi
chain
domain
interfac
find
togeth
phylogenet
relationship
antibodi
receptor
indic
substanti
shift
natur
fc
receptor
bind
evolut
specif
interact
provid
inhibitori
motif
cytoplasm
tail
fc
portion
igi
shown
enhanc
calcium
releas
chicken
b
cell
line
express
common
activ
gchain
activ
requir
aggreg
igi
suggest
immun
complex
requir
trigger
respons
compar
sequenc
databas
homologu
identifi
clone
compris
nonigybind
igybind
isoform
display
differ
affin
addit
fcrrelat
gene
design
gallu
gallu
fcr
ggfcr
recent
identifi
receptor
select
bind
igi
consist
four
extracellular
ig
domain
surprisingli
ggfcr
close
relat
chicken
lcr
encod
gene
locat
chromosom
distinct
lcr
fcr
gene
cluster
recent
chicken
yolk
sac
igi
receptor
fcri
respons
igi
transport
yolk
embryon
circul
character
homologu
mammalian
phospholipas
receptor
member
mannos
receptor
famili
deposit
yolk
howev
mediat
anoth
receptor
yet
clone
specif
address
differ
approach
one
factor
restrict
deposit
igm
iga
yolk
appear
polymer
natur
fc
region
structur
may
also
import
sinc
anseriform
speci
like
duck
preferenti
incorpor
fulllength
igi
egg
yolk
truncat
isoform
igi
dfc
sitespecif
mutagenesi
experi
use
mammalian
igg
sequenc
extrapol
inform
upsilon
heavi
chain
suggest
interfac
especi
residu
posit
within
essenti
interact
receptor
besid
function
interact
fc
receptor
igi
differ
igg
varieti
aspect
directli
attribut
molecul
mention
earlier
phylogenet
distanc
avian
immun
system
mammalian
protein
like
increas
immun
respons
toward
respect
antigen
mean
igi
often
rais
epitop
highli
conserv
protein
mammal
fail
provid
immunolog
respons
extent
overal
antibodi
affin
mammalian
igg
igi
relat
still
investig
monoclon
igi
antibodi
fragment
gener
exhibit
reactiv
least
compar
igg
unpublish
observ
compar
mammalian
igg
igi
lack
flexibl
hing
region
thu
thought
rigid
immunoglobulin
hingeless
structur
also
found
mammalian
ige
igi
therefor
exhibit
structur
featur
mammalian
ige
igg
find
also
support
structur
analysi
igi
fc
portion
potenti
reduc
molecular
flexibl
might
associ
decreas
suscept
proteolyt
degrad
fragment
nevertheless
igi
fragment
papain
trypsin
igi
like
mammalian
igg
reason
stabl
store
sever
month
standard
condit
seriou
limit
igi
therapeut
applic
howev
reduc
stabil
low
ph
contrast
igg
antigen
bind
activ
igi
decreas
significantli
acid
condit
demonstr
circular
dichroism
analys
loss
activ
chicken
igi
accompani
signific
conform
chang
fact
attribut
fewer
intramolecular
disulphid
linkag
exampl
rabbit
igg
today
product
polyclon
igi
immun
chicken
offer
routin
basi
sever
commerci
compani
gener
approach
subject
constraint
convent
immun
mammal
nevertheless
advantag
chicken
nonmammalian
speci
bloodless
isol
immunoglobulin
perhap
yet
fulli
appreci
exploit
egg
yolk
collect
immun
provid
concentr
igi
rang
mgml
start
sourc
recoveri
immunoglobulin
rel
simpl
method
may
use
extract
antigenspecif
immunoglobulin
egg
yolk
sever
commerci
kit
avail
decis
use
particular
protocol
usual
brought
intend
downstream
applic
well
expertis
equip
avail
one
frequent
use
procedur
involv
protein
precipit
ammonium
sulphat
dextran
sulphat
polyethylen
glycol
peg
particularli
effici
method
compris
two
success
precipit
use
peg
remov
lipid
follow
peg
precipit
igi
variant
protocol
includ
emulsif
step
ad
one
volum
chloroform
one
volum
egg
yolk
rather
use
fraction
precipit
igi
also
purifi
convent
ion
exchang
chromatographi
anoth
strategi
use
addit
polish
step
reli
thiophil
adsorpt
chromatographi
tac
target
protein
adsorb
sulphon
thioether
ligand
interact
mediat
predominantli
aromat
residu
elut
condit
mild
compar
convent
method
use
purifi
antibodi
protein
g
l
none
bind
igi
nevertheless
purif
strategi
polish
step
base
affin
ligand
might
help
particular
high
puriti
desir
antiigi
antibodi
synthet
ligand
avail
spectrum
reagent
could
broaden
use
solubl
igi
receptor
construct
affin
molecul
affin
medium
instanc
superantigenlik
protein
staphylococcu
aureu
use
affin
purif
igi
unpublish
data
addit
recombin
express
chir
mammalian
cell
escherichia
coli
highli
effici
potenti
provid
highli
homogen
protein
fraction
unpublish
data
polyclon
prepar
igi
suitabl
mani
routin
applic
diagnost
approach
howev
use
monoclon
reagent
imper
accuraci
reproduc
standardis
even
though
hybridoma
technolog
appli
avian
speci
technic
obstacl
togeth
low
secret
rate
fusion
line
limit
efficaci
obstacl
howev
circumv
use
recombin
antibodi
technolog
address
need
monoclon
igi
antibodi
essenti
repres
sum
antigenbind
moieti
fc
portion
essenti
dimer
effector
function
facilit
detect
use
convent
secondari
reagent
decid
reagent
particular
applic
import
consid
whether
authent
fulli
avian
antibodi
requir
whether
part
may
fact
deriv
speci
avian
igi
chimer
igi
avian
constant
domain
murin
bind
moieti
recent
produc
studi
despit
heterolog
origin
transfect
mammalian
cell
abl
stabli
express
differ
igybas
construct
success
secret
immunoglobulin
mammalian
cell
requir
chaperon
interact
nascent
immunoglobulin
chain
guid
fold
assembl
bind
immunoglobulin
protein
bip
bind
transient
domain
ig
heavi
chain
ch
variabl
region
light
heavi
chain
vh
vl
provid
site
coval
attach
cl
interact
stabli
bip
absenc
light
chain
pronounc
differ
amino
acid
sequenc
within
antibodi
constant
domain
antibodi
bird
mammal
potenti
loss
specif
interact
site
chaperon
nascent
immunoglobulin
chain
might
conceiv
affect
effici
mammalian
cell
secret
avian
antibodi
instanc
igi
found
effici
secret
possibl
result
less
stringent
control
er
secret
machineri
sinc
effici
econom
way
produc
antibodi
alway
desir
yield
might
case
improv
use
bind
moieti
preexist
murin
hybridoma
gener
chimer
igi
moreov
enorm
divers
synthet
antibodi
librari
avail
today
mean
immun
anim
necessarili
need
deriv
suitabl
binder
inde
framework
synthet
human
avian
variabl
region
success
convert
igi
deriv
produc
eukaryot
host
primari
sequenc
igi
heavi
chain
provid
two
potenti
nlink
glycosyl
site
locat
fc
region
name
carbohydr
analysi
nativ
igi
reveal
monoglucosyl
oligomannos
type
oligosaccharid
oligomannos
type
oligosaccharid
biantennari
complex
type
oligosaccharid
first
two
report
major
glycoform
igi
differ
speci
attribut
glycosyl
site
addit
termin
sialic
acid
identifi
nativ
igi
signific
differ
overal
glycosyl
pattern
nativ
recombin
igi
produc
mammalian
cell
could
detect
use
common
lectin
therebi
confirm
recombin
igi
sourc
close
resembl
nativ
immunoglobulin
howev
recombin
product
igi
differ
host
like
result
variabl
glycosyl
pattern
result
biochem
properti
recombin
nativ
igi
like
differ
sinc
glycosyl
immunoglobulin
implic
varieti
physiolog
mechan
also
influenc
physicochem
behaviour
recombin
igi
may
alway
suitabl
potenti
applic
envisag
summaris
authent
polyclon
igi
rel
easi
gener
recombin
antibodi
technolog
provid
access
avian
monoclon
antibodi
moreov
preexist
antibodi
convert
igi
necessari
specif
individu
applic
egg
constitut
common
compon
diet
therefor
toler
human
immun
system
topic
administr
igi
may
therefor
repres
attract
approach
immunotherapi
reduc
risk
toxic
side
effect
wide
accept
igi
appli
human
mucos
surfac
exhibit
immunogen
potenti
detriment
effect
might
anticip
patient
sensit
egg
protein
includ
igi
aspect
discuss
later
context
assay
perform
see
section
although
immunogen
appli
system
oral
uptak
igi
antibodi
open
new
possibl
therapeut
intervent
respect
varieti
patholog
includ
limit
pulmonari
gastrointestin
infect
overview
see
tabl
approach
effect
reduc
bacteri
viral
load
anim
studi
well
clinic
trial
human
cohort
besid
suitabl
approach
target
infect
process
igi
suggest
block
inhibit
deliveri
patholog
condit
demand
specif
reagent
substanti
amount
chicken
antibodi
well
establish
antitoxin
andor
passiv
vaccin
instanc
specif
antivenom
igi
neutral
bacteri
toxin
use
treat
snake
bite
inde
antivenom
igi
provid
higher
bioactiv
antidot
rais
hors
applic
egg
yolk
provid
continu
suppli
potenti
superior
reagent
today
consum
becom
increasingli
interest
food
supposedli
promot
health
reduc
risk
diseas
incorpor
egg
yolk
immun
chicken
certain
foodstuff
exampl
drink
yoghurt
mouthwash
provid
consum
function
food
potenti
protect
pathogen
socal
edibl
vaccin
without
consum
synthet
pharmaceut
potenti
drawback
igi
therapeut
prophylact
approach
reduc
stabil
harsh
condit
acid
environ
especi
true
gastrointestin
applic
differ
strategi
improv
therapeut
efficaci
therefor
evolv
includ
varieti
techniqu
stabil
control
releas
igi
far
therapeut
intervent
mention
confin
polyclon
nativ
igi
obtain
egg
yolk
immun
hen
contrast
therapeut
potenti
recombin
monoclon
igi
molecul
remain
explor
perhap
greatest
potenti
igi
paratop
fuse
human
fc
region
lie
appli
combinatori
approach
biolog
chemistri
demand
high
effici
possibl
simpl
straightforward
techniqu
chicken
therefor
provid
ideal
basi
gener
larg
immun
antibodi
fragment
librari
compar
mammalian
speci
inher
complex
mammalian
diversif
mechan
make
difficult
recov
antibodi
sequenc
especi
true
human
mice
genet
organ
mammal
base
modular
use
recombin
broad
panel
v
j
segment
diversifi
sever
differ
mechan
therefor
access
amplifi
mous
human
repertoir
requir
larg
set
differ
oligonucleotid
cover
entir
set
v
segment
prone
preferenti
amplif
high
abund
transcript
potenti
loss
particular
v
segment
pcr
chicken
genet
diversif
achiev
differ
heavi
light
chain
loci
consist
singl
function
v
j
gene
segment
heavi
chain
rearrang
use
convent
v
j
recombin
mechan
order
gener
larg
divers
antibodi
repertoir
allow
affin
matur
upon
antigen
prime
avian
speci
util
uniqu
mode
dna
recombin
term
gene
convers
review
process
short
dna
segment
nonfunct
v
pseudogen
locat
upstream
insert
rearrang
gene
modul
primari
structur
henc
bind
characterist
result
immunoglobulin
howev
end
rearrang
gene
remain
unalt
thu
allow
divers
chicken
humour
immun
system
recov
use
two
pair
primer
first
avian
repertoir
clone
decad
ago
somewhat
surprisingli
first
littl
attent
paid
librari
fact
might
attribut
lack
familiar
chicken
immun
need
establish
recombin
antibodi
technolog
past
year
chicken
librari
attract
wider
interest
accordingli
report
isol
chickenderiv
antibodi
fragment
steadili
increas
overview
see
tabl
target
antibodi
includ
difficult
antigen
structur
hapten
highli
conserv
protein
complex
crude
extract
interestingli
avian
vhvl
scaffold
employ
gener
immun
also
well
semisynthet
singl
chain
antibodi
scfv
librari
approach
allow
entir
avian
recombin
antibodi
format
aim
especi
diagnost
exclus
use
singl
variabl
region
gene
make
human
avian
antibodi
fragment
practic
human
rodent
antibodi
plethora
variabl
region
gene
could
shown
engin
antiprion
antibodi
human
framework
cdr
graft
follow
optim
use
provid
proof
principl
approach
summari
gener
use
avian
immun
repertoir
librari
repres
power
approach
potenti
complement
establish
method
provid
novel
origin
approach
addit
differ
spectrum
epitop
recogn
avian
immun
system
could
facilit
develop
novel
therapeut
particularli
technolog
chimer
chickenmammalian
fusion
fulli
exploit
gener
one
intrigu
extraordinari
characterist
igi
lack
interact
mammalian
immun
compon
make
igi
especi
suit
applic
use
mammalian
counterpart
prone
unwant
crossreact
instanc
proteom
pretreat
serum
sampl
igi
specif
neutral
highli
abund
serum
compon
found
improv
downstream
analys
anoth
studi
identif
underrepres
serum
protein
diseas
marker
candid
discoveri
simplifi
specif
igi
use
block
reagent
approach
facilit
gener
characterist
igi
eas
product
low
incid
crossreact
case
immunoassay
homolog
mammalian
immunoglobulin
may
deleteri
effect
perform
mani
differ
type
immunoassay
particular
approach
use
immunoglobulin
bioactiv
molecul
captur
detect
analyt
often
affect
heterophil
antibodi
andor
high
level
nonspecif
bind
addit
antigenindepend
specif
bind
via
immunoglobulin
fc
receptor
lectin
nonimmunoglobulinbas
interact
eg
mediat
complement
factor
result
falseposit
falseneg
result
recent
summar
tabl
overview
therapeut
approach
human
anim
passiv
protect
rainbow
trout
lee
et
al
estim
preval
assay
interfer
heterophil
antibodi
rang
thorough
analysi
sera
anticea
assay
format
reveal
result
potenti
fals
approach
elimin
heterophil
antibodi
interfer
includ
remov
inactiv
interf
immunoglobulin
eg
precipit
peg
use
variou
buffer
addit
modif
assay
antibodi
proteolyt
remov
fc
fragment
unlik
howev
singl
method
resolv
problem
altern
recombin
modif
like
human
anim
deriv
antibodi
use
singlechain
fragment
use
possibl
includ
shift
nonimmunoglobulin
affin
system
affibodi
aptam
approach
cours
like
suffer
particular
drawback
inher
molecul
take
forego
account
chickenderiv
antibodi
either
polyclon
monoclon
prepar
offer
sever
obviou
advantag
mammalian
homologu
certain
applic
sinc
interact
rheumatoid
factor
rf
human
antimous
igg
antibodi
hama
complement
compon
mammalian
fc
receptor
recombin
avian
libraryderiv
antibodi
fragment
scfv
low
function
affin
sinc
monoval
first
group
express
igi
mammalian
cell
abl
produc
heterotetramer
igi
antibodi
cho
cell
reclon
igi
heavi
light
chain
chicken
hybridoma
cell
line
addit
greunk
et
al
could
demonstr
mammalian
cell
express
varieti
artifici
igi
construct
includ
chimer
igi
antibodi
homodimer
scfvconstruct
latter
show
increas
secret
effici
antibodi
construct
larger
individu
scfv
may
effect
immunoassay
system
chicken
scfv
larg
semisynthet
phage
display
librari
recognis
kda
heatshock
protein
mycobacterium
bovi
convert
larger
bival
construct
close
resembl
igi
molecul
gallibodi
could
use
immunocaptur
elisa
could
readili
conjug
colloid
gold
nanoparticl
although
current
use
immunotest
base
murin
monoclon
antibodi
recent
provid
evid
potenti
use
monoclon
igi
way
avoid
interfer
rf
heterophil
antibodi
human
serum
sampl
work
laboratori
shown
monoclon
polyclon
igi
antibodi
bind
neither
mammalian
fcg
receptor
human
high
affin
ige
receptor
despit
similar
amino
acid
sequenc
human
ige
avian
igi
low
degre
relationship
mammalian
avian
fc
receptor
explain
find
diagnost
applic
advantag
igi
may
undermin
preval
antichicken
antibodi
certain
individu
although
variou
henegg
protein
implic
allergi
vivo
vitro
investig
earli
report
occurr
human
igyspecif
antibodi
scarc
focuss
igemedi
hypersensit
reaction
one
studi
demonstr
eggallerg
patient
exhibit
specif
ige
bind
one
egg
yolkderiv
antivir
chicken
immunoglobulin
contrast
accord
anoth
studi
overal
allergen
potenti
igi
anim
model
appear
low
extent
igyspecif
antibodi
igg
isotyp
relev
immunolog
analys
occur
individu
sensit
egg
yolk
remain
establish
yet
anoth
potenti
sourc
unwant
interfer
immunoassay
might
result
interact
carbohydr
bind
serum
protein
mannosebind
lectin
mbl
nlink
glycostructur
igi
fc
region
howev
problem
larg
depend
particular
express
host
need
produc
igi
could
conceiv
counteract
delet
particular
asparagin
residu
respons
interact
nglycosyl
site
elimin
recombin
igi
without
sever
affect
bind
behaviour
product
effici
unpublish
observ
although
may
well
worthwhil
convert
mani
exist
hybridomaderiv
antibodi
use
problemat
immunoassay
recombin
igi
biochem
characterist
murineavian
chimera
might
differ
authent
avian
antibodi
interfer
may
still
aris
protein
interact
specif
rodent
immunoglobulin
variabl
region
hama
potenti
consequ
therapeut
intervent
use
chimer
therapeut
antibodi
today
howev
sinc
human
antibodi
becom
readili
avail
clinic
applic
decreas
preval
hama
expect
anoth
approach
improv
reliabl
immunoassay
base
igi
one
receptor
develop
recent
immunoassay
aim
detect
circul
ig
speci
specif
pathogen
antigen
pool
human
sera
repres
immunologist
first
choic
control
sometim
readili
avail
usual
expens
vari
qualiti
instead
artifici
substitut
human
refer
sera
specif
virtual
protein
interest
could
easili
establish
unpublish
result
use
avian
polyclon
certain
circumst
monoclon
igi
complex
igyspecif
ectodomain
genet
fuse
human
ig
fc
domain
bind
moieti
summari
readi
avail
polyclon
eggyolk
immunoglobulin
rise
recombin
technolog
gener
monoclon
igi
focuss
attent
use
characterist
avian
antibodi
moreov
fact
monoclon
igi
igylik
construct
obtain
combinatori
librari
sometim
without
immunis
like
make
igi
manifest
much
wide
use
research
diagnost
therapeut
